Global Plasma-derived Factor VIII Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Plasma-derived Factor VIII market size was valued at USD 9014.6 million in 2023 and is forecast to a readjusted size of USD 13070 million by 2030 with a CAGR of 5.5% during review period.
RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of hemophilia A and the rising awareness about the importance of early diagnosis and treatment have led to a growing demand for Factor VIII products. The availability of plasma-derived Factor VIII provides an effective treatment option for patients who require clotting factor replacement therapy. Secondly, advancements in manufacturing techniques and purification processes have improved the safety and efficacy of plasma-derived Factor VIII products. Stringent regulatory standards and guidelines for plasma collection and fractionation have instilled confidence among healthcare providers and patients regarding the safety of these products.
The Global Info Research report includes an overview of the development of the Plasma-derived Factor VIII industry chain, the market status of Hospital (200IU, 250IU), Pharmacy (200IU, 250IU), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma-derived Factor VIII.
Regionally, the report analyzes the Plasma-derived Factor VIII markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma-derived Factor VIII market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Plasma-derived Factor VIII market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma-derived Factor VIII industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 200IU, 250IU).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma-derived Factor VIII market.
Regional Analysis: The report involves examining the Plasma-derived Factor VIII market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma-derived Factor VIII market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Plasma-derived Factor VIII:
Company Analysis: Report covers individual Plasma-derived Factor VIII manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma-derived Factor VIII This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Plasma-derived Factor VIII. It assesses the current state, advancements, and potential future developments in Plasma-derived Factor VIII areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma-derived Factor VIII market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Plasma-derived Factor VIII market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Plasma-derived Factor VIII product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma-derived Factor VIII, with price, sales, revenue and global market share of Plasma-derived Factor VIII from 2019 to 2024.
Chapter 3, the Plasma-derived Factor VIII competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma-derived Factor VIII breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma-derived Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma-derived Factor VIII.
Chapter 14 and 15, to describe Plasma-derived Factor VIII sales channel, distributors, customers, research findings and conclusion.
RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of hemophilia A and the rising awareness about the importance of early diagnosis and treatment have led to a growing demand for Factor VIII products. The availability of plasma-derived Factor VIII provides an effective treatment option for patients who require clotting factor replacement therapy. Secondly, advancements in manufacturing techniques and purification processes have improved the safety and efficacy of plasma-derived Factor VIII products. Stringent regulatory standards and guidelines for plasma collection and fractionation have instilled confidence among healthcare providers and patients regarding the safety of these products.
The Global Info Research report includes an overview of the development of the Plasma-derived Factor VIII industry chain, the market status of Hospital (200IU, 250IU), Pharmacy (200IU, 250IU), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma-derived Factor VIII.
Regionally, the report analyzes the Plasma-derived Factor VIII markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma-derived Factor VIII market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Plasma-derived Factor VIII market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma-derived Factor VIII industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 200IU, 250IU).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma-derived Factor VIII market.
Regional Analysis: The report involves examining the Plasma-derived Factor VIII market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma-derived Factor VIII market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Plasma-derived Factor VIII:
Company Analysis: Report covers individual Plasma-derived Factor VIII manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma-derived Factor VIII This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Plasma-derived Factor VIII. It assesses the current state, advancements, and potential future developments in Plasma-derived Factor VIII areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma-derived Factor VIII market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Plasma-derived Factor VIII market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- 200IU
- 250IU
- Hospital
- Pharmacy
- Takeda
- Octapharma
- CSL
- Grifols
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Plasma-derived Factor VIII product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma-derived Factor VIII, with price, sales, revenue and global market share of Plasma-derived Factor VIII from 2019 to 2024.
Chapter 3, the Plasma-derived Factor VIII competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma-derived Factor VIII breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma-derived Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma-derived Factor VIII.
Chapter 14 and 15, to describe Plasma-derived Factor VIII sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Plasma-derived Factor VIII
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma-derived Factor VIII Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 200IU
1.3.3 250IU
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma-derived Factor VIII Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Plasma-derived Factor VIII Market Size & Forecast
1.5.1 Global Plasma-derived Factor VIII Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Plasma-derived Factor VIII Sales Quantity (2019-2030)
1.5.3 Global Plasma-derived Factor VIII Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Factor VIII Product and Services
2.1.4 Takeda Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma-derived Factor VIII Product and Services
2.2.4 Octapharma Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Octapharma Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Plasma-derived Factor VIII Product and Services
2.3.4 CSL Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Plasma-derived Factor VIII Product and Services
2.4.4 Grifols Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Grifols Recent Developments/Updates
2.5 Greencross
2.5.1 Greencross Details
2.5.2 Greencross Major Business
2.5.3 Greencross Plasma-derived Factor VIII Product and Services
2.5.4 Greencross Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Greencross Recent Developments/Updates
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Plasma-derived Factor VIII Product and Services
2.6.4 Kedrion Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Kedrion Recent Developments/Updates
2.7 BPL
2.7.1 BPL Details
2.7.2 BPL Major Business
2.7.3 BPL Plasma-derived Factor VIII Product and Services
2.7.4 BPL Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BPL Recent Developments/Updates
2.8 Hualan Bio
2.8.1 Hualan Bio Details
2.8.2 Hualan Bio Major Business
2.8.3 Hualan Bio Plasma-derived Factor VIII Product and Services
2.8.4 Hualan Bio Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hualan Bio Recent Developments/Updates
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma-derived Factor VIII Product and Services
2.9.4 RAAS Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 RAAS Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLASMA-DERIVED FACTOR VIII BY MANUFACTURER
3.1 Global Plasma-derived Factor VIII Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma-derived Factor VIII Revenue by Manufacturer (2019-2024)
3.3 Global Plasma-derived Factor VIII Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Plasma-derived Factor VIII by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Plasma-derived Factor VIII Manufacturer Market Share in 2023
3.4.2 Top 6 Plasma-derived Factor VIII Manufacturer Market Share in 2023
3.5 Plasma-derived Factor VIII Market: Overall Company Footprint Analysis
3.5.1 Plasma-derived Factor VIII Market: Region Footprint
3.5.2 Plasma-derived Factor VIII Market: Company Product Type Footprint
3.5.3 Plasma-derived Factor VIII Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plasma-derived Factor VIII Market Size by Region
4.1.1 Global Plasma-derived Factor VIII Sales Quantity by Region (2019-2030)
4.1.2 Global Plasma-derived Factor VIII Consumption Value by Region (2019-2030)
4.1.3 Global Plasma-derived Factor VIII Average Price by Region (2019-2030)
4.2 North America Plasma-derived Factor VIII Consumption Value (2019-2030)
4.3 Europe Plasma-derived Factor VIII Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma-derived Factor VIII Consumption Value (2019-2030)
4.5 South America Plasma-derived Factor VIII Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma-derived Factor VIII Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
5.2 Global Plasma-derived Factor VIII Consumption Value by Type (2019-2030)
5.3 Global Plasma-derived Factor VIII Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
6.2 Global Plasma-derived Factor VIII Consumption Value by Application (2019-2030)
6.3 Global Plasma-derived Factor VIII Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
7.2 North America Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
7.3 North America Plasma-derived Factor VIII Market Size by Country
7.3.1 North America Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
7.3.2 North America Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
8.2 Europe Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
8.3 Europe Plasma-derived Factor VIII Market Size by Country
8.3.1 Europe Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
8.3.2 Europe Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma-derived Factor VIII Market Size by Region
9.3.1 Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Plasma-derived Factor VIII Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
10.2 South America Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
10.3 South America Plasma-derived Factor VIII Market Size by Country
10.3.1 South America Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
10.3.2 South America Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma-derived Factor VIII Market Size by Country
11.3.1 Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Plasma-derived Factor VIII Market Drivers
12.2 Plasma-derived Factor VIII Market Restraints
12.3 Plasma-derived Factor VIII Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plasma-derived Factor VIII and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma-derived Factor VIII
13.3 Plasma-derived Factor VIII Production Process
13.4 Plasma-derived Factor VIII Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma-derived Factor VIII Typical Distributors
14.3 Plasma-derived Factor VIII Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Plasma-derived Factor VIII
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma-derived Factor VIII Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 200IU
1.3.3 250IU
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma-derived Factor VIII Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Plasma-derived Factor VIII Market Size & Forecast
1.5.1 Global Plasma-derived Factor VIII Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Plasma-derived Factor VIII Sales Quantity (2019-2030)
1.5.3 Global Plasma-derived Factor VIII Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Factor VIII Product and Services
2.1.4 Takeda Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma-derived Factor VIII Product and Services
2.2.4 Octapharma Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Octapharma Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Plasma-derived Factor VIII Product and Services
2.3.4 CSL Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Plasma-derived Factor VIII Product and Services
2.4.4 Grifols Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Grifols Recent Developments/Updates
2.5 Greencross
2.5.1 Greencross Details
2.5.2 Greencross Major Business
2.5.3 Greencross Plasma-derived Factor VIII Product and Services
2.5.4 Greencross Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Greencross Recent Developments/Updates
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Plasma-derived Factor VIII Product and Services
2.6.4 Kedrion Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Kedrion Recent Developments/Updates
2.7 BPL
2.7.1 BPL Details
2.7.2 BPL Major Business
2.7.3 BPL Plasma-derived Factor VIII Product and Services
2.7.4 BPL Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BPL Recent Developments/Updates
2.8 Hualan Bio
2.8.1 Hualan Bio Details
2.8.2 Hualan Bio Major Business
2.8.3 Hualan Bio Plasma-derived Factor VIII Product and Services
2.8.4 Hualan Bio Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hualan Bio Recent Developments/Updates
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma-derived Factor VIII Product and Services
2.9.4 RAAS Plasma-derived Factor VIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 RAAS Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLASMA-DERIVED FACTOR VIII BY MANUFACTURER
3.1 Global Plasma-derived Factor VIII Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma-derived Factor VIII Revenue by Manufacturer (2019-2024)
3.3 Global Plasma-derived Factor VIII Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Plasma-derived Factor VIII by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Plasma-derived Factor VIII Manufacturer Market Share in 2023
3.4.2 Top 6 Plasma-derived Factor VIII Manufacturer Market Share in 2023
3.5 Plasma-derived Factor VIII Market: Overall Company Footprint Analysis
3.5.1 Plasma-derived Factor VIII Market: Region Footprint
3.5.2 Plasma-derived Factor VIII Market: Company Product Type Footprint
3.5.3 Plasma-derived Factor VIII Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plasma-derived Factor VIII Market Size by Region
4.1.1 Global Plasma-derived Factor VIII Sales Quantity by Region (2019-2030)
4.1.2 Global Plasma-derived Factor VIII Consumption Value by Region (2019-2030)
4.1.3 Global Plasma-derived Factor VIII Average Price by Region (2019-2030)
4.2 North America Plasma-derived Factor VIII Consumption Value (2019-2030)
4.3 Europe Plasma-derived Factor VIII Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma-derived Factor VIII Consumption Value (2019-2030)
4.5 South America Plasma-derived Factor VIII Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma-derived Factor VIII Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
5.2 Global Plasma-derived Factor VIII Consumption Value by Type (2019-2030)
5.3 Global Plasma-derived Factor VIII Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
6.2 Global Plasma-derived Factor VIII Consumption Value by Application (2019-2030)
6.3 Global Plasma-derived Factor VIII Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
7.2 North America Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
7.3 North America Plasma-derived Factor VIII Market Size by Country
7.3.1 North America Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
7.3.2 North America Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
8.2 Europe Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
8.3 Europe Plasma-derived Factor VIII Market Size by Country
8.3.1 Europe Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
8.3.2 Europe Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma-derived Factor VIII Market Size by Region
9.3.1 Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Plasma-derived Factor VIII Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
10.2 South America Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
10.3 South America Plasma-derived Factor VIII Market Size by Country
10.3.1 South America Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
10.3.2 South America Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma-derived Factor VIII Market Size by Country
11.3.1 Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Plasma-derived Factor VIII Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Plasma-derived Factor VIII Market Drivers
12.2 Plasma-derived Factor VIII Market Restraints
12.3 Plasma-derived Factor VIII Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plasma-derived Factor VIII and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma-derived Factor VIII
13.3 Plasma-derived Factor VIII Production Process
13.4 Plasma-derived Factor VIII Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma-derived Factor VIII Typical Distributors
14.3 Plasma-derived Factor VIII Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Plasma-derived Factor VIII Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma-derived Factor VIII Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma-derived Factor VIII Product and Services
Table 6. Takeda Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. Octapharma Basic Information, Manufacturing Base and Competitors
Table 9. Octapharma Major Business
Table 10. Octapharma Plasma-derived Factor VIII Product and Services
Table 11. Octapharma Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Octapharma Recent Developments/Updates
Table 13. CSL Basic Information, Manufacturing Base and Competitors
Table 14. CSL Major Business
Table 15. CSL Plasma-derived Factor VIII Product and Services
Table 16. CSL Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CSL Recent Developments/Updates
Table 18. Grifols Basic Information, Manufacturing Base and Competitors
Table 19. Grifols Major Business
Table 20. Grifols Plasma-derived Factor VIII Product and Services
Table 21. Grifols Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Grifols Recent Developments/Updates
Table 23. Greencross Basic Information, Manufacturing Base and Competitors
Table 24. Greencross Major Business
Table 25. Greencross Plasma-derived Factor VIII Product and Services
Table 26. Greencross Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Greencross Recent Developments/Updates
Table 28. Kedrion Basic Information, Manufacturing Base and Competitors
Table 29. Kedrion Major Business
Table 30. Kedrion Plasma-derived Factor VIII Product and Services
Table 31. Kedrion Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Kedrion Recent Developments/Updates
Table 33. BPL Basic Information, Manufacturing Base and Competitors
Table 34. BPL Major Business
Table 35. BPL Plasma-derived Factor VIII Product and Services
Table 36. BPL Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. BPL Recent Developments/Updates
Table 38. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Bio Major Business
Table 40. Hualan Bio Plasma-derived Factor VIII Product and Services
Table 41. Hualan Bio Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Hualan Bio Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Plasma-derived Factor VIII Product and Services
Table 46. RAAS Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. RAAS Recent Developments/Updates
Table 48. Global Plasma-derived Factor VIII Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Plasma-derived Factor VIII Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Plasma-derived Factor VIII Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Plasma-derived Factor VIII, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Plasma-derived Factor VIII Production Site of Key Manufacturer
Table 53. Plasma-derived Factor VIII Market: Company Product Type Footprint
Table 54. Plasma-derived Factor VIII Market: Company Product Application Footprint
Table 55. Plasma-derived Factor VIII New Market Entrants and Barriers to Market Entry
Table 56. Plasma-derived Factor VIII Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Plasma-derived Factor VIII Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Plasma-derived Factor VIII Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Plasma-derived Factor VIII Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Plasma-derived Factor VIII Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Plasma-derived Factor VIII Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Plasma-derived Factor VIII Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Plasma-derived Factor VIII Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Plasma-derived Factor VIII Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Plasma-derived Factor VIII Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Plasma-derived Factor VIII Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Plasma-derived Factor VIII Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Plasma-derived Factor VIII Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Plasma-derived Factor VIII Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Plasma-derived Factor VIII Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Plasma-derived Factor VIII Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Plasma-derived Factor VIII Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Plasma-derived Factor VIII Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Plasma-derived Factor VIII Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Plasma-derived Factor VIII Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Plasma-derived Factor VIII Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Plasma-derived Factor VIII Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Plasma-derived Factor VIII Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Plasma-derived Factor VIII Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Plasma-derived Factor VIII Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Plasma-derived Factor VIII Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Plasma-derived Factor VIII Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Plasma-derived Factor VIII Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Plasma-derived Factor VIII Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Plasma-derived Factor VIII Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Plasma-derived Factor VIII Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Plasma-derived Factor VIII Raw Material
Table 116. Key Manufacturers of Plasma-derived Factor VIII Raw Materials
Table 117. Plasma-derived Factor VIII Typical Distributors
Table 118. Plasma-derived Factor VIII Typical Customers
Table 1. Global Plasma-derived Factor VIII Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma-derived Factor VIII Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma-derived Factor VIII Product and Services
Table 6. Takeda Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. Octapharma Basic Information, Manufacturing Base and Competitors
Table 9. Octapharma Major Business
Table 10. Octapharma Plasma-derived Factor VIII Product and Services
Table 11. Octapharma Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Octapharma Recent Developments/Updates
Table 13. CSL Basic Information, Manufacturing Base and Competitors
Table 14. CSL Major Business
Table 15. CSL Plasma-derived Factor VIII Product and Services
Table 16. CSL Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CSL Recent Developments/Updates
Table 18. Grifols Basic Information, Manufacturing Base and Competitors
Table 19. Grifols Major Business
Table 20. Grifols Plasma-derived Factor VIII Product and Services
Table 21. Grifols Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Grifols Recent Developments/Updates
Table 23. Greencross Basic Information, Manufacturing Base and Competitors
Table 24. Greencross Major Business
Table 25. Greencross Plasma-derived Factor VIII Product and Services
Table 26. Greencross Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Greencross Recent Developments/Updates
Table 28. Kedrion Basic Information, Manufacturing Base and Competitors
Table 29. Kedrion Major Business
Table 30. Kedrion Plasma-derived Factor VIII Product and Services
Table 31. Kedrion Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Kedrion Recent Developments/Updates
Table 33. BPL Basic Information, Manufacturing Base and Competitors
Table 34. BPL Major Business
Table 35. BPL Plasma-derived Factor VIII Product and Services
Table 36. BPL Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. BPL Recent Developments/Updates
Table 38. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Bio Major Business
Table 40. Hualan Bio Plasma-derived Factor VIII Product and Services
Table 41. Hualan Bio Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Hualan Bio Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Plasma-derived Factor VIII Product and Services
Table 46. RAAS Plasma-derived Factor VIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. RAAS Recent Developments/Updates
Table 48. Global Plasma-derived Factor VIII Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Plasma-derived Factor VIII Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Plasma-derived Factor VIII Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Plasma-derived Factor VIII, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Plasma-derived Factor VIII Production Site of Key Manufacturer
Table 53. Plasma-derived Factor VIII Market: Company Product Type Footprint
Table 54. Plasma-derived Factor VIII Market: Company Product Application Footprint
Table 55. Plasma-derived Factor VIII New Market Entrants and Barriers to Market Entry
Table 56. Plasma-derived Factor VIII Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Plasma-derived Factor VIII Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Plasma-derived Factor VIII Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Plasma-derived Factor VIII Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Plasma-derived Factor VIII Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Plasma-derived Factor VIII Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Plasma-derived Factor VIII Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Plasma-derived Factor VIII Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Plasma-derived Factor VIII Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Plasma-derived Factor VIII Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Plasma-derived Factor VIII Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Plasma-derived Factor VIII Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Plasma-derived Factor VIII Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Plasma-derived Factor VIII Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Plasma-derived Factor VIII Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Plasma-derived Factor VIII Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Plasma-derived Factor VIII Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Plasma-derived Factor VIII Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Plasma-derived Factor VIII Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Plasma-derived Factor VIII Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Plasma-derived Factor VIII Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Plasma-derived Factor VIII Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Plasma-derived Factor VIII Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Plasma-derived Factor VIII Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Plasma-derived Factor VIII Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Plasma-derived Factor VIII Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Plasma-derived Factor VIII Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Plasma-derived Factor VIII Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Plasma-derived Factor VIII Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Plasma-derived Factor VIII Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Plasma-derived Factor VIII Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Plasma-derived Factor VIII Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Plasma-derived Factor VIII Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Plasma-derived Factor VIII Raw Material
Table 116. Key Manufacturers of Plasma-derived Factor VIII Raw Materials
Table 117. Plasma-derived Factor VIII Typical Distributors
Table 118. Plasma-derived Factor VIII Typical Customers
LIST OF FIGURES
Figure 1. Plasma-derived Factor VIII Picture
Figure 2. Global Plasma-derived Factor VIII Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma-derived Factor VIII Consumption Value Market Share by Type in 2023
Figure 4. 200IU Examples
Figure 5. 250IU Examples
Figure 6. Global Plasma-derived Factor VIII Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Plasma-derived Factor VIII Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Global Plasma-derived Factor VIII Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Plasma-derived Factor VIII Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Plasma-derived Factor VIII Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Plasma-derived Factor VIII Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Plasma-derived Factor VIII Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Plasma-derived Factor VIII by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Plasma-derived Factor VIII Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Plasma-derived Factor VIII Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Plasma-derived Factor VIII Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Plasma-derived Factor VIII Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Plasma-derived Factor VIII Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Plasma-derived Factor VIII Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Plasma-derived Factor VIII Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Plasma-derived Factor VIII Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Plasma-derived Factor VIII Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Plasma-derived Factor VIII Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Plasma-derived Factor VIII Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Plasma-derived Factor VIII Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Plasma-derived Factor VIII Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Plasma-derived Factor VIII Consumption Value Market Share by Region (2019-2030)
Figure 52. China Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Plasma-derived Factor VIII Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Plasma-derived Factor VIII Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Plasma-derived Factor VIII Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Plasma-derived Factor VIII Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Plasma-derived Factor VIII Market Drivers
Figure 73. Plasma-derived Factor VIII Market Restraints
Figure 74. Plasma-derived Factor VIII Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2023
Figure 77. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 78. Plasma-derived Factor VIII Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Plasma-derived Factor VIII Picture
Figure 2. Global Plasma-derived Factor VIII Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma-derived Factor VIII Consumption Value Market Share by Type in 2023
Figure 4. 200IU Examples
Figure 5. 250IU Examples
Figure 6. Global Plasma-derived Factor VIII Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Plasma-derived Factor VIII Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Global Plasma-derived Factor VIII Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Plasma-derived Factor VIII Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Plasma-derived Factor VIII Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Plasma-derived Factor VIII Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Plasma-derived Factor VIII Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Plasma-derived Factor VIII by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Plasma-derived Factor VIII Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Plasma-derived Factor VIII Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Plasma-derived Factor VIII Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Plasma-derived Factor VIII Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Plasma-derived Factor VIII Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Plasma-derived Factor VIII Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Plasma-derived Factor VIII Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Plasma-derived Factor VIII Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Plasma-derived Factor VIII Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Plasma-derived Factor VIII Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Plasma-derived Factor VIII Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Plasma-derived Factor VIII Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Plasma-derived Factor VIII Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Plasma-derived Factor VIII Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Plasma-derived Factor VIII Consumption Value Market Share by Region (2019-2030)
Figure 52. China Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Plasma-derived Factor VIII Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Plasma-derived Factor VIII Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Plasma-derived Factor VIII Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Plasma-derived Factor VIII Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Plasma-derived Factor VIII Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Plasma-derived Factor VIII Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Plasma-derived Factor VIII Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Plasma-derived Factor VIII Market Drivers
Figure 73. Plasma-derived Factor VIII Market Restraints
Figure 74. Plasma-derived Factor VIII Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2023
Figure 77. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 78. Plasma-derived Factor VIII Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
